Annals of Indian Academy of Neurology
  Users Online: 7588 Home | About the Journal | InstructionsCurrent Issue | Back IssuesLogin      Print this page Email this page  Small font size Default font size Increase font size


 
DEBATES IN NEUROLOGY
Year : 2010  |  Volume : 13  |  Issue : 3  |  Page : 163
 

Use of angiotensin-converting enzyme inhibitors immediately after stroke: Commentary


Department of Neurology, Nizam Institute of Medical Sciences, Hyderabad, India

Date of Submission14-Jan-2010
Date of Decision14-Jan-2010
Date of Acceptance28-Aug-2010
Date of Web Publication5-Oct-2010

Correspondence Address:
Subhash Kaul
Department of Neurology, Nizam Institute of Medical Sciences, Hyderabad
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0972-2327.70872

Rights and Permissions

 



How to cite this article:
Kaul S. Use of angiotensin-converting enzyme inhibitors immediately after stroke: Commentary. Ann Indian Acad Neurol 2010;13:163

How to cite this URL:
Kaul S. Use of angiotensin-converting enzyme inhibitors immediately after stroke: Commentary. Ann Indian Acad Neurol [serial online] 2010 [cited 2019 Oct 22];13:163. Available from: http://www.annalsofian.org/text.asp?2010/13/3/163/70872


This issue of Annals of Indian Academy of Neurology features a debate on the controversial topic, 'ACE inhibitors will help in improving stroke outcome if given immediately after stroke'. Dr. M.V. Padma favors the proposition, whereas, Dr. Rohit Bhatia opposes it. The topic is controversial because, while on the one hand the presence of severe hypertension in acute stroke is feared to be associated with the risk of developing cerebral edema , on the other hand antihypertensive treatment in acute stroke may lead to worsening of deficits due to reduced cerebral perfusion. [1] There are some studies, however, which suggest that no clinically significant change in cerebral perfusion occurs after the administration of Angiotensin Converting Enzyme (ACE) Inhibitors to patients soon after an ischemic stroke. [2],[3] Dr. M.V. Padma emphasizes the fact that the mechanism of improvement in the stroke outcome may not be due to the effects of blood pressure reduction, but due to the endothelial-protective effects of the ACE Inhibitors, as shown in studies such as the Heart Outcomes Prevention Evaluation (HOPE) and Perindopril pRotection aGainst REcurrent Stroke Study (PROGRESS). [4],[5] Dr. Rohit Bhatia convincingly rebuts this argument by commenting that the endothelial protective effects of ACE Inhibitors have been demonstrated only by their long-term use for stroke prevention and have not been tested in the setting of an acute stroke. [4],[5] According to him there is a need for more studies to assess the theoretical effects of ACE Inhibitors on blood pressure, inflammatory cascade, and neuroprotection, in the acute phase of a stroke. He therefore strikes a cautionary note against going overboard in treating acute strokes with ACE Inhibitors, as there is not enough Class I evidence to support such practice at present. Dr. Padma, in support of her contention, cites studies that show that the use of ACE Inhibitors in the acute stage may improve the outcome. However, this inference was indirect, as the patients in these studies were already taking ACE Inhibitors at the onset of acute stroke and were not put on these drugs after the onset of the stroke. [6],[7]

To strike a balance, as per the current evidence-based literature, there are concerns about instituting anti-hypertensive therapy immediately after a stroke, even if it is with ACE Inhibitors. Hypertension immediately after the stroke may be reactive and its presence may be necessary to compensate for the global and local autoregulatory failure following an acute stroke. [8] Even a mild reduction in blood pressure may be risky. The solution probably lies in taking a middle path. It seems prudent to withhold all antihypertensive medication for the first 24 hours after stroke onset, with some exceptions. [9] One may then cautiously and gradually begin to reduce the blood pressure, particularly in patients with underlying cerebrovascular atherostenotic lesions. The first choice should probably be ACE Inhibitors, pending the results of clinical trials testing other antihypertensive agents, in acute stroke.

 
   References Top

1.Rodges A, Neal B, MacMohan S. The effects of blood pressure lowering in cerebrovascular disease. Neurol Rev Int 1997;2:12-5.   Back to cited text no. 1      
2.Waldemar G, Vorstrup S, Andersen AR, Pedersen H, Paulson OB.Angiotensin-converting enzyme inhibition and region and cerebral blood flow in acute stroke. J Cardiovasc Pharmacol 1989;14:722-9.  Back to cited text no. 2  [PUBMED]    
3.Dyker AG, Grosset DG, Lees KR. Perindopril reduces blood pressure but not cerebral blood flow in patients with recent cerebral ischemic stroke. Stroke 1997;28:580-3.  Back to cited text no. 3  [PUBMED]  [FULLTEXT]  
4.Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of angiotensin-converting enzyme inhibitor on death from cardiovascular causes, myocardial infarction, and stroke in high-risk patients. Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. New Engl J Med 2000;342:145-53.  Back to cited text no. 4  [PUBMED]  [FULLTEXT]  
5.PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-41.  Back to cited text no. 5  [PUBMED]  [FULLTEXT]  
6.Selim M, Savitz S, Linfante I, Louis C, Schlaug G. Effect of pre-stroke use of ACE inhibitors on ischemic stroke severity. BMC Neurol 2005;5:10.  Back to cited text no. 6      
7.Di Napoli M, Papa F. Angiotensin-converting enzyme inhibitor use is associated with reduced plasma concentration of C-reactive protein in patients with first-ever ischemic stroke. Stroke 2003;34:2922-9.  Back to cited text no. 7  [PUBMED]  [FULLTEXT]  
8.Yatsu FM, Zivin J. Hypertension in acute ischemic strokes. Not to treat. Arch Neurol 1985;42:999-1000.  Back to cited text no. 8  [PUBMED]  [FULLTEXT]  
9.Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al. Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association /American Stroke Association. Stroke 2007;38:1655-711.  Back to cited text no. 9  [PUBMED]  [FULLTEXT]  



This article has been cited by
1 Angiotensin-receptor blockade in acute stroke
Rajendran, S.P.
Annals of Indian Academy of Neurology. 2011; 14(2): 142-143
[Pubmed]



 

Top
Print this article  Email this article
Previous article Next article

    

 
   Search
 
   Next article
   Previous article 
   Table of Contents
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (639 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  


    References

 Article Access Statistics
    Viewed1827    
    Printed81    
    Emailed0    
    PDF Downloaded72    
    Comments [Add]    
    Cited by others 1    

Recommend this journal